Skip to main content

Holiday schedule

Quest Diagnostics Patient Service Centers will be closed on Monday, September 7th, 2026 in observance of the Labor Day Holiday.  Have a healthy, happy holiday.

Hide
Quest Diagnostics

Signatures of Disease and Resistance: FLT3 in Review

AMP 2023

Association for Molecular Pathology

Salt Lake City, UT, Nov 14-18 2023

Poster presentation: Signatures of Disease and Resistance: FLT3 in Review

Authors: Grubbs C, Ma C, Ulrich M,Allen D, Cronin NL, Escalada S, Godsey JH, Gonong B, Hochstein P, Le A, Nguyen T, Racke FK, Utulo S, Van Ness ME

Specialty: Oncology, Hematology

Related content

On-Demand Webinar
Hemepath Master Class Myeloid Neoplasms MPN MDS AML
Conference Presentation
A novel highly sensitive approach for residual disease detection in AML using digital PCR
Test FAQ
AML Rapid Mutation Panel
Test FAQ
FLT3 Mutation Analysis
Test FAQ
Isocitrate Dehydrogenase 1 and 2 (IDH1/IDH2) Mutation Analysis (IDH1 and IDH2 Mutation)
Publication
Acute Promyelocytic Leukemia with Rare Genetic Aberrations: A Report of Three Cases
Publication
Optical Genome Mapping in Acute Myeloid Leukemia: A Multicenter Evaluation
Audio Podcast
Optimize Oncology Care with Clinical Pathways

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.